PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Ahrens, W.* ; Greiser, K.H.* ; Linseisen, J. ; Pischon, T.* ; Pigeot, I.*

Erforschung von Erkrankungen in der NAKO Gesundheitsstudie. Die wichtigsten gesundheitlichen Endpunkte und ihre Erfassung.

The investigation of health outcomes in the German National Cohort: The most relevant endpoints and their assessment.

Bundesgesundheitsbl.-Gesund. 63, 376-384 (2020)
Verlagsversion DOI PMC
Open Access Hybrid
Creative Commons Lizenzvertrag
The focus of the German National Cohort, the largest population-based cohort study in Germany to date, is the investigation of the most important widespread diseases, such as cardiovascular diseases, diabetes, cancer, neurological and psychiatric disorders, and frequent respiratory and infectious diseases. This cohort will answer questions on the development of these diseases and on the impact of genetic, environmental and lifestyle-related risk factors. Another focus is on the identification of early, subclinical markers of emerging diseases. To answer these questions, a comprehensive assessment of these health outcomes as well as of all potential determinants and precursors is mandatory. This paper describes the various health outcomes that are assessed in the German National Cohort, as well as the examination modules that are applied for deep phenotyping of study participants. Repeated collection of biosamples as well as functional measurements and application of modern imaging techniques at various time points allow for assessing the dynamics of physiological changes related to the individuals' health status. The prognostic value of these changes for disease development will be explored and translated to novel approaches for prevention and personalised medicine. Incident diseases are being assessed through self-reports by study participants and through record linkage with data from health insurances and cancer registries. Additional information about clinical diagnoses is obtained from the treating physicians to ensure the highest possible validity.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
1.059
0.777
1
2
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Review
Schlagwörter Biomarkers ; Epidemiology ; Phenotyping ; Physical Examinations ; Widespread Diseases; Atrial-fibrillation; Registry Data; Life-style; Epidemiology; Heart; Prevention; Secondary; Linkage; Intervention; Cancer
Sprache deutsch
Veröffentlichungsjahr 2020
HGF-Berichtsjahr 2020
ISSN (print) / ISBN 1436-9990
e-ISSN 1437-1588
Zeitschrift Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
Quellenangaben Band: 63, Heft: 4, Seiten: 376-384 Artikelnummer: , Supplement: ,
Verlag Springer
Verlagsort One New York Plaza, Suite 4600, New York, Ny, United States
Begutachtungsstatus Peer reviewed
Institut(e) Independent Research Group Clinical Epidemiology (KEPI)
POF Topic(s) 30202 - Environmental Health
Forschungsfeld(er) Genetics and Epidemiology
PSP-Element(e) G-502900-001
DOI 10.1007/s00103-020-03111-0
WOS ID WOS:000522831700002
Scopus ID 85081934564
PubMed ID 32157353
Erfassungsdatum 2020-04-17
[➜Korrektur melden]